{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:20:19Z","timestamp":1793931619586,"version":"4.8.0"},"reference-count":25,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1205388"],"award-info":[{"award-number":["OPP1205388"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"South African Medical Research Council through the Strategic Health Innovation Partnerships","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"TB REACH Wave 6 project of Stop TB Partnership","award":["STBP\/TBREACH\/GSA\/W6-34"],"award-info":[{"award-number":["STBP\/TBREACH\/GSA\/W6-34"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The tuberculosis (TB) MATE study evaluated whether a differentiated care approach (DCA) based on tablet-taking data from Wisepill evriMED digital adherence technology could improve TB treatment adherence. The DCA entailed a stepwise increase in adherence support starting from short message service (SMS) to phone calls, followed by home visits and motivational counselling. We explored feasibility of this approach with providers in implementing clinics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Between June 2020 and February 2021, in-depth interviews were conducted in the provider\u2019s preferred language, audiorecorded, transcribed verbatim and translated. The interview guide included three categories: feasibility, system-level challenges and sustainability of the intervention. We assessed saturation and used thematic analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Primary healthcare clinics in three provinces of South Africa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>We conducted 25 interviews with 18 staff and 7 stakeholders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Three major themes emerged: First, providers were supportive of the intervention being integrated into the TB programme and were eager to be trained on the device as it helped to monitor treatment adherence. Second, there were challenges in the adoption system such as shortage of human resources which could serve as a barrier to information provision once the intervention is scaled up. Healthcare workers reported that some patients received incorrect SMS\u2019s due to delays in the system that contributed to distrust. Third, DCA was considered as a key aspect of the intervention by some staff and stakeholders since it allowed for support based on individual needs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It was feasible to monitor TB treatment adherence using the evriMED device and DCA. To ensure successful scale-up of the adherence support system, emphasis will need to be placed on ensuring that the device and the network operate optimally and continued support on adhering to treatment which will enable people with TB to take ownership of their treatment journey and help overcome TB-related stigma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>Pan African Trial Registry PACTR201902681157721.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-065202","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T15:42:07Z","timestamp":1678290127000},"page":"e065202","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-1729","authenticated-orcid":false,"given":"Rachel","family":"Mukora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3974-5961","authenticated-orcid":false,"given":"Noriah","family":"Maraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pren","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Thulani","family":"Mbatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-3915","authenticated-orcid":false,"given":"Kavindhran","family":"Velen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-3754","authenticated-orcid":false,"given":"Katherine","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-9586","authenticated-orcid":false,"given":"Candice Maylene","family":"Chetty-Makkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"2023030807202638000_13.3.e065202.1","unstructured":"WHO . Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Available: https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22ZA%22"},{"key":"2023030807202638000_13.3.e065202.2","unstructured":"WHO . Global tuberculosis report 2018. Geneva: World Health Organization,"},{"key":"2023030807202638000_13.3.e065202.3","doi-asserted-by":"crossref","unstructured":"Cramm JM , Finkenfl\u00fcgel HJM , M\u00f8ller V , et al . Tb treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis. BMC Public Health 2010;10:72. doi:10.1186\/1471-2458-10-72","DOI":"10.1186\/1471-2458-10-72"},{"key":"2023030807202638000_13.3.e065202.4","doi-asserted-by":"crossref","unstructured":"Knight M , van Zyl RL , Sanne I , et al . Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment. South Afr J HIV Med 2015;16:346. doi:10.4102\/sajhivmed.v16i1.346","DOI":"10.4102\/sajhivmed.v16i1.346"},{"key":"2023030807202638000_13.3.e065202.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2009.03.021"},{"key":"2023030807202638000_13.3.e065202.6","doi-asserted-by":"publisher","DOI":"10.4102\/curationis.v39i1.1575"},{"key":"2023030807202638000_13.3.e065202.7","doi-asserted-by":"crossref","unstructured":"Liu X , Lewis JJ , Zhang H , et al . Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med 2015;12:e1001876. doi:10.1371\/journal.pmed.1001876","DOI":"10.1371\/journal.pmed.1001876"},{"key":"2023030807202638000_13.3.e065202.8","doi-asserted-by":"crossref","unstructured":"Bionghi N , Daftary A , Maharaj B , et al . Pilot evaluation of a second-generation electronic pill box for adherence to bedaquiline and antiretroviral therapy in drug-resistant TB\/HIV co-infected patients in KwaZulu-Natal, South Africa. BMC Infect Dis 2018;18:171. doi:10.1186\/s12879-018-3080-2","DOI":"10.1186\/s12879-018-3080-2"},{"key":"2023030807202638000_13.3.e065202.9","unstructured":"H\u00fcsler J . Evaluation of the on cue compliance service pilot: testing the use of SMS reminders in the treatment of tuberculosis in cape town, south africa. 2005."},{"key":"2023030807202638000_13.3.e065202.10","doi-asserted-by":"crossref","unstructured":"Subbaraman R , de Mondesert L , Musiimenta A , et al . Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health 2018;3:e001018. doi:10.1136\/bmjgh-2018-001018","DOI":"10.1136\/bmjgh-2018-001018"},{"key":"2023030807202638000_13.3.e065202.11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/PPA.S135540","article-title":"Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda","volume":"11","author":"Hermans","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2023030807202638000_13.3.e065202.12","doi-asserted-by":"crossref","unstructured":"Cross A , Gupta N , Liu B , et al . 99DOTS: A low-cost approach to monitoring and improving medication adherence. Tenth International Conference on Information and Communication Technologies and Development (ICTD \u201919); 2019","DOI":"10.1145\/3287098.3287102"},{"key":"2023030807202638000_13.3.e065202.13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"key":"2023030807202638000_13.3.e065202.14","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(19)30293-4","article-title":"Video-observed therapy for tuberculosis: strengthening care","volume":"393","author":"Fraser","year":"2019","journal-title":"Lancet"},{"key":"2023030807202638000_13.3.e065202.15","doi-asserted-by":"crossref","unstructured":"Maraba N , Orrell C , Chetty-Makkan CM , et al . Evaluation of adherence monitoring system using evrimed with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial. Trials 2021;22:389. doi:10.1186\/s13063-021-05337-y","DOI":"10.1186\/s13063-021-05337-y"},{"key":"2023030807202638000_13.3.e065202.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.02.002"},{"key":"2023030807202638000_13.3.e065202.17","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czp055"},{"key":"2023030807202638000_13.3.e065202.18","first-page":"114","article-title":"Qualitative research in health care","volume":"320","author":"Pope","year":"2000","journal-title":"Analysing Qualitative Data BMJ"},{"key":"2023030807202638000_13.3.e065202.19","doi-asserted-by":"crossref","unstructured":"Charmaz K . Constructing grounded theory: A practical guide through qualitative analysis nurse res. 2006;13:84.","DOI":"10.7748\/nr.13.4.84.s4"},{"key":"2023030807202638000_13.3.e065202.20","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12699"},{"key":"2023030807202638000_13.3.e065202.21","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182055138"},{"key":"2023030807202638000_13.3.e065202.22","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-015-0077-4"},{"key":"2023030807202638000_13.3.e065202.23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.idc.2016.02.010","article-title":"Drug-resistant tuberculosis: challenges and progress","volume":"30","author":"Kurz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2023030807202638000_13.3.e065202.24","doi-asserted-by":"crossref","unstructured":"Subbaraman R , Nathavitharana RR , Mayer KH , et al . Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care. PLoS Med 2019;16:e1002754. doi:10.1371\/journal.pmed.1002754","DOI":"10.1371\/journal.pmed.1002754"},{"key":"2023030807202638000_13.3.e065202.25","doi-asserted-by":"crossref","unstructured":"Thomas BE , Kumar JV , Periyasamy M , et al . Acceptability of the medication event reminder monitor for promoting adherence to multidrug-resistant tuberculosis therapy in two Indian cities: qualitative study of patients and health care providers. J Med Internet Res 2021;23:e23294. doi:10.2196\/23294","DOI":"10.2196\/23294"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-065202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T15:42:23Z","timestamp":1678290143000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-065202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,3]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bmjopen-2022-065202"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-065202","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}